Kee Ming Chia

1.4k total citations
19 papers, 779 citations indexed

About

Kee Ming Chia is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kee Ming Chia has authored 19 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kee Ming Chia's work include HER2/EGFR in Cancer Research (5 papers), Estrogen and related hormone effects (4 papers) and Cancer-related Molecular Pathways (4 papers). Kee Ming Chia is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Estrogen and related hormone effects (4 papers) and Cancer-related Molecular Pathways (4 papers). Kee Ming Chia collaborates with scholars based in Australia, United Kingdom and United States. Kee Ming Chia's co-authors include Elgene Lim, Sue Haupt, Ygal Haupt, Andrew Burgess, David M. Thomas, Ji Liu, Ali Naderi, Glenn Francis, Megan A. O’Brien and Myles Brown and has published in prestigious journals such as Nature Communications, Cancer Research and Journal of Investigative Dermatology.

In The Last Decade

Kee Ming Chia

18 papers receiving 773 citations

Peers

Kee Ming Chia

ONCOL

PRM

GENET

Allison Landman United States

Rosanna Lacalamita Italy

Marc Payton United States

Marie Fernet France

Peter Čamaj Germany

Sarah E. Golding United States

Anne Fassl Germany

Davide Pellacani United Kingdom

R. Gätje Germany

Songbo Qiu United States

Allison Landman United States

Kee Ming Chia

700 ×1.6

449 ×1.2

ONCOL

193 ×1.1

187 ×1.2

PRM

63 ×0.4

GENET

Citations per year, relative to Kee Ming Chia Kee Ming Chia (= 1×) peers Allison Landman

Countries citing papers authored by Kee Ming Chia

Since Specialization

Citations

This map shows the geographic impact of Kee Ming Chia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kee Ming Chia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kee Ming Chia more than expected).

Fields of papers citing papers by Kee Ming Chia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kee Ming Chia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kee Ming Chia. The network helps show where Kee Ming Chia may publish in the future.

Co-authorship network of co-authors of Kee Ming Chia

This figure shows the co-authorship network connecting the top 25 collaborators of Kee Ming Chia. A scholar is included among the top collaborators of Kee Ming Chia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kee Ming Chia. Kee Ming Chia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Brazil, L., et al.. (2022). P11.30.A Stereotactic Radiosurgery (SRS) for brain metastases in breast cancer: An evaluation of outcomes at a UK tertiary centre. Neuro-Oncology. 24(Supplement_2). ii63–ii63. 1 indexed citations

Laven‐Law, Geraldine, Kee Ming Chia, Marie Pickering, et al.. (2022). Abstract PD2-02: Combination CDK4/6 inhibition and AR agonism suppresses the growth of CDK4/6 inhibitor resistant breast cancers. Cancer Research. 82(4_Supplement). PD2–2. 2 indexed citations

Portman, Neil, Heloisa Milioli, Sarah Alexandrou, et al.. (2020). MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer. Breast Cancer Research. 22(1). 87–87. 49 indexed citations

Chia, Kee Ming, Sanjeev Kumar, Andrew Parker, et al.. (2020). Estrogen receptor positive breast cancer patient–derived xenograft models in translational research. Current Opinion in Endocrine and Metabolic Research. 15. 31–36. 1 indexed citations

Papachristou, Evangelia K., Kamal Kishore, Andrew N. Holding, et al.. (2018). A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes. Nature Communications. 9(1). 2311–2311. 84 indexed citations

Chia, Kee Ming, Heloisa Milioli, Neil Portman, et al.. (2018). Non-canonical AR activity facilitates endocrine resistance in breast cancer. Endocrine Related Cancer. 26(2). 251–264. 28 indexed citations

Patel, Vinod, Janine Mansi, Samit Ghosh, et al.. (2017). MRONJ risk of adjuvant bisphosphonates in early stage breast cancer. BDJ. 224(2). 74–79. 21 indexed citations

Burgess, Andrew, Kee Ming Chia, Sue Haupt, et al.. (2016). Clinical Overview of MDM2/X-Targeted Therapies. Frontiers in Oncology. 6. 7–7. 250 indexed citations

Spoerri, Loredana, Kelly Brooks, Kee Ming Chia, et al.. (2016). A novel ATM‐dependent checkpoint defect distinct from loss of function mutation promotes genomic instability in melanoma. Pigment Cell & Melanoma Research. 29(3). 329–339. 9 indexed citations

10.

Chia, Kee Ming, et al.. (2016). Long QT Syndrome Associated With a Mutation in the β3 Subunit of the Cardiac Sodium Channel (SCN3B) Gene in Two Siblings. Heart Lung and Circulation. 25. S284–S285. 1 indexed citations

11.

Chia, Kee Ming, Megan A. O’Brien, Myles Brown, & Elgene Lim. (2015). Targeting the Androgen Receptor in Breast Cancer. Current Oncology Reports. 17(2). 4–4. 84 indexed citations

12.

Martin, Paul T., et al.. (2015). Conscious sedation for electrophysiological procedures: a prospective multi centre experience. Heart Lung and Circulation. 24. S226–S226.

13.

Oakes, Vanessa, Brittney S. Harrington, Won‐Jae Lee, et al.. (2014). Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle. Cell Cycle. 13(20). 3302–3311. 66 indexed citations

14.

Brooks, Kelly, Kee Ming Chia, Loredana Spoerri, et al.. (2013). Defective Decatenation Checkpoint Function Is a Common Feature of Melanoma. Journal of Investigative Dermatology. 134(1). 150–158. 19 indexed citations

15.

Gabrielli, Brian, Kee Ming Chia, & Robyn Warrener. (2011). Finally, how histone deacetylase inhibitors disrupt mitosis!. Cell Cycle. 10(16). 2658–2661. 7 indexed citations

16.

Naderi, Ali, Kee Ming Chia, & Ji Liu. (2011). Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer. Breast Cancer Research. 13(2). R36–R36. 46 indexed citations

17.

Chia, Kee Ming, Ji Liu, Glenn Francis, & Ali Naderi. (2011). A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer. Neoplasia. 13(2). 154–166. 84 indexed citations

18.

Chia, Kee Ming, et al.. (2010). The Histone Deacetylase Inhibitor MGCD0103 Has Both Deacetylase and Microtubule Inhibitory Activity. Molecular Pharmacology. 78(3). 436–443. 9 indexed citations

19.

Warrener, Robyn, Kee Ming Chia, William Warren, Kelly Brooks, & Brian Gabrielli. (2010). Inhibition of Histone Deacetylase 3 Produces Mitotic Defects Independent of Alterations in Histone H3 Lysine 9 Acetylation and Methylation. Molecular Pharmacology. 78(3). 384–393. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact